Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.1 USD | -2.36% | +3.91% | +35.01% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.01% | 2.91B | |
+18.30% | 125B | |
+13.99% | 109B | |
-2.72% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-11.75% | 16.64B | |
-0.06% | 13.45B | |
+22.36% | 11.32B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Cantor Fitzgerald Cuts PTC Therapeutics' Price Target to $45 From $51, Keeps Overweight Rating